Investing.com - Co-Diagnostics reported on Thursday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Co-Diagnostics announced earnings per share of $-0.040 on revenue of $5.1M. Analysts polled by Investing.com anticipated EPS of $0.060 on revenue of $15.33M.
Co-Diagnostics shares are down 28.35% from the beginning of the year and are trading at $3.260 , down-from-52-week-high.
Co-Diagnostics follows other major Healthcare sector earnings this month
Co-Diagnostics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar